コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 probes), and 3 (7%) were M. avium; none were M. intracellulare.
2 enicum and M. phocaicum, and M. chimaera and M. intracellulare.
3 5% confidence interval = 1.25 to 22.73) than M. intracellulare.
4 Most patients (77%) had M. intracellulare.
5 nvestigate the public health significance of M. intracellulare.
6 larly, 130 divergent ORFs were identified in M. intracellulare.
7 M. avium could invade more efficiently than M. intracellulare.
8 the isolates from HIV-negative patients were M. intracellulare.
9 es within the 16S rRNA genes of M. avium and M. intracellulare.
10 l mechanism of host defense against M. avium-M. intracellulare.
11 trains genetically diverse from M. avium and M. intracellulare.
12 sis induce killing of intracellular M. avium-M. intracellulare.
13 ecies, including M. smegmatis, M. avium, and M. intracellulare.
14 clinical relapse/reinfection than those with M. intracellulare.
15 57.82 degrees C (57.05 to 58.60 degrees C); M. intracellulare, 54.46 degrees C (53.69 to 55.23 degre
16 species distribution, comprising 54 (81.8%) M. intracellulare, 6 (9.1%) M. avium, 5 (7.6%) M. colomb
17 However, concentrations of Legionella spp., M. intracellulare, Acanthamoeba spp., and M. avium peake
20 encing, 49 (90.7%) respiratory isolates were M. intracellulare and 4 (7.4%) were Mycobacterium chimae
21 nts has not been epidemiologically linked to M. intracellulare and appears to be unique to M. avium.
26 Mycobacterium avium complex (MAC; M. avium, M. intracellulare, and "nonspecific or X" MAC) are emerg
30 95% confidence interval [CI], 1.33-3.44) or M. intracellulare (AOR, 3.12; 95% CI, 1.62-5.99) were mo
33 ncy virus type 1-infected patients, M. avium-M. intracellulare can infect almost every tissue and org
35 were identified as belonging to the M. avium-M. intracellulare complex (but not M. paratuberculosis),
36 r the rapid diagnosis of Mycobacterium avium-M. intracellulare complex (MAC) bacteremia in patients w
37 icate that the currently identified M. avium-M. intracellulare complex includes strains genetically d
38 elerate the diagnosis of Mycobacterium avium-M. intracellulare complex infections, an immunomagnetic
39 r understand the role of Mycobacterium avium-M. intracellulare complex isolates in human disease.
41 ional differentiation of Mycobacterium avium-M. intracellulare complex strains into M. avium and M. i
42 or 26 M. tuberculosis complex, 9 M. avium, 3 M. intracellulare complex, 3 M. kansasii, 4 M. gordonae,
43 ient samples were LiPA positive for M. avium-M. intracellulare complex, and all were identified as M.
44 erentiates M. tuberculosis complex, M. avium-M. intracellulare complex, and the following mycobacteri
45 terium tuberculosis complex and the M. avium-M. intracellulare complex, as well as rapid- and slow-gr
46 y coupled to magnetic beads with an M. avium-M. intracellulare complex-specific PCR protocol based on
50 or fingerprinting of respiratory isolates of M. intracellulare from patients with underlying bronchie
51 contrast, 41 of the 65 (63.1%) patients with M. intracellulare had probable to definite infection, a
52 each of 10 clinical isolates of M. avium and M. intracellulare identified by conventional methods wer
54 tracellulare was observed only when M. avium-M. intracellulare-infected cells were treated with 10 mM
55 eath of intracellular mycobacteria, M. avium-M. intracellulare-infected human monocytes were treated
56 ed, H2O2-induced apoptotic death of M. avium-M. intracellulare-infected monocytes and its association
57 esent study, a long-term culture of M. avium-M. intracellulare-infected monocytes was used to further
59 sults suggest that, among non-AIDS patients, M. intracellulare is more pathogenic and tends to infect
60 enetic analysis revealed a high diversity of M. intracellulare isolates and their evolutionary relati
61 solates did not contain IS1245 and 7% of the M. intracellulare isolates were found to carry IS1245.
62 used to characterize 32 Mycobacterium avium-M. intracellulare isolates, 4 Pseudomonas aeruginosa iso
65 quiline shows potential for the treatment of M. intracellulare lung disease, but optimization of trea
66 NTM-PD patients due to Mycobacterium avium, M. intracellulare, M. abscessus, or M. massiliense and t
69 e following mycobacterial species: M. avium, M. intracellulare, M. kansasii, M. chelonae group, M. go
70 an inhibitory effect on Mycobacterium avium-M. intracellulare (MAI) when blood collected and process
71 acellulare complex strains into M. avium and M. intracellulare may provide a tool to better understan
73 by MycoID as being M. avium (n = 98; 61.1%), M. intracellulare (n = 57; 35.8%), and mixed M. avium an
74 Rep-PCR also generated DNA fingerprints from M. intracellulare (n = 8) and MAC(x) (n = 2) strains.
78 negative with species-specific M. avium and M. intracellulare probes), and 3 (7%) were M. avium; non
79 e synthesized: MAV and MIN, for M. avium and M. intracellulare, respectively, and MYCOB, for the slow
80 stered in the distinct clades separated from M. intracellulare strains originating from other countri
84 alysis presented clade-specific proteins for M. intracellulare, such as PE and PPE protein families.
85 otide probes that specifically detect either M. intracellulare, the two M. avium subspecies associate
86 We compared the abilities of M. avium and M. intracellulare to tolerate the acidic conditions of t
87 ison of pretreatment and relapse isolates of M. intracellulare uncovered mutations in a previously un
88 identified functions essential for growth of M. intracellulare under conditions relevant to the host
92 reduction in CFU) of intracellular M. avium-M. intracellulare was observed only when M. avium-M. int
99 that were present in M. avium but absent in M. intracellulare were identified, including some that m